Tuberculosis and HIV-needed: A new paradigm for the control and management of linked epidemics

MedGenMed Medscape General Medicine

Volumn 9, Issue 3, 2007, Pages

  Tsiouris, Simon J ^a   Gandhi, Neel R ^b   El Sadr, Wafaa M ^a   Friedland, Gerald ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DIAGNOSTIC TEST; DIRECTLY OBSERVED THERAPY; DISEASE ASSOCIATION; EPIDEMIC; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE MANPOWER; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PUBLIC HEALTH SERVICE; RESOURCE MANAGEMENT; TUBERCULOSIS; TUBERCULOSIS CONTROL; REVIEW;

HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 34848818815     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dye C SS, Dolin P, Pathania V, Raviglione MC. Consensus Statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-686.
2. WHO. Global tuberculosis control: surveillance, planning, financing. WHO report 2005. Geneva: World Health Organization; 2005. Available at: http://www.who.int/tb/publications/global_report/2005/en/ Accessed July 20, 2007.
3. Wilkinson D, Davies GR. The increasing burden of tuberculosis in rural South Africa-impact of the HIV epidemic [see comment]. South Afr Med J. 1997;87:447-450.
4. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa [see comment]. Lancet 2006;368:1575-1580.
5. Colebunders RL, Ryder RW, Nzilambi N, et al. HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am Rev Resp Dis. 1989; 139:1082-1085. [u Abstract u].
6. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA. 1992;268:1581-1587. [u Abstract u].
7. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol. 2006;44:2844-2850. [u Abstract u].
8. Rangaka MX, Diwakar L, Seldon R, et al. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-Infected Africans. Clin Infect Dis. 2007;44:1639-1646. [u Abstract u].
9. Moore DA, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diangostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004;42:4432-4437. [u Abstract u].
10. Arias M, Mello FC, Pavon A, et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007;44:674-680. [u Abstract u].
11. McIlleron H, Meintjes G, Burman WJ, Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis. 2007;196:S63-S75. [u Abstract u].
12. Gasana M. Vandebriel G, Kabanda, G, et al. Tuberculosis in Rwanda: challenges to reaching the targets. Bull WHO. 2007;85:383-384.
13. International epidemiologic databases to evaluate AIDS. Available at: http://www.iedea-hiv.org Accessed July 20, 2007.
14. Consortium to respond effectively to the AIDS/TB epidemic. Available at http://www.tbhiv-create.org Accessed July 20, 2007.
15. WHO. Interim Policy on Collaborative TB/HIV Activities. Geneva: Stop TB Department and Department of HIV/AIDS/WHO; 2004. Available at http://whqlibdoc.who.int/hq/2004/WHO_HTM_TB_2004.330.pdf Accessed July 20, 2005.
16. The Stop TB Strategy: World Health Organization; 2006. Report No.: WHO/ HTM/STB/2006.37. Available at: http://www.stoptb.org/resource_center/ assets/documents/The_Stop_TB_Strategy_Final.pdf. Accessed July 20, 2007.
17. Vandebriel G, Kabanda G, Turinawe K, Sahabo R, Mugabo J, Gasana M. Early Results of Implementation of a National Policy on TB Screening in People Living with HIV Attending ART Clinics in Rwanda. In: HIV/AIDS Implementer's Meeting 2007; Kigali, Rwanda; 2007.
18. Chimzizi RB, Harries AD, Manda E, Khonyongwa A, Salaniponi FM. Counselling, HIV testing and adjunctive cotrimoxazole for TB patients in Malawi: from research to routine implementation. [see comment]. Int J Tuberculosis Lung Dis. 2004;8:938-944.
19. Gasana M, Vandebriel G, Kabanda, G, et al. Integrating tuberculosis and HIV care in rural Rwanda. International Journal of Tuberculosis & Lung Disease; Accepted for publication May 3rd 2007.
20. Jack C, Lalloo U, Abdool-Karim Q, et al. A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. J AIDS. 2004;36:929-934.
21. Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS. 2004;18:S21-S25. [u Abstract u].
22. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. [see comment]. N Engl J Med. 2005;353:2325-2334. [u Abstract u].
23. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/ HIV program collaboration and-integration: 3 case studies. J. Infect Dis. 2007;196:S114-S123. [u Abstract u].
24. Farmer P, Leandre F, Mukherjee J, Gupta R, Tarter, L, Kim JY. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy) [see comment]. Bull WHO. 2001;79:1145-1151. [u Abstract u].
25. Miti S, Mfungwe V, Reijer P, Maher D. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS in Ndola, Zambia. Int J Tuberculosis Lung Dis. 2003;7:S92-S98.
26. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberculosis L ung Dis. 2003;7:S56-S62.
27. El-Sadr W, Medard F, Dickerson M. The Harlem family model: a unique approach to the treatment of tuberculosis. J Public Health Manag Pract. 1995;1:48-51.
28. Walton DA, Farmer PE, Lambert W, Leandre F, Koenig SP, Mukherjee JS. Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti [see comment]. J Public Health Policy. 2004;25:137-158. [u Abstract u].